The RGD story: A personal account

Matrix Biology

Volumn 22, Issue 6, 2003, Pages 459-465

  Ruoslahti, Erkki ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYLGLYCYLASPARTYLSERINE; FIBRONECTIN; INTEGRIN;

AMINO ACID SEQUENCE; CELL ANCHORAGE; CELL ISOLATION; CELL SELECTION; CELL SURFACE; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNODIFFUSION; IMMUNOELECTROPHORESIS; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN VARIANT; REVIEW;

EID: 0344256437     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(03)00083-0     Document Type: Article

References (43)

1. Arap W., Pasqualini R., Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science. 279:1998;377-380.
2. Auerbach R., Lu W.C., Pardon E., Gumkowski F., Kaminska G., Kaminski M. Specificity of adhesion between murine tumor cells and capillary endothelium: an in vitro correlate of preferential metastasis in vivo. Cancer Res. 47:1987;1492-1496.
3. Barnes D., Wolfe R., Serrero G., McClure D., Sato G. Effects of a serum spreading factor on growth and morphology of cells in serum-free medium. J. Supramol. Struct. 14:(1):1980;47-63.
4. Brooks P.C., Montgomery A.M., Rosenfeld M., et al. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 79:1994;1157-1164.
5. Cheresh D., Pytela R., Pierschbacher M.D., Klier F.G., Ruoslahti E., Reisfeld R. An Arg-Gly-Asp-directed receptor on the surface of human melanoma cells exists in a divalent cation-dependent functional complex with the disialoganglioside GD2. J. Cell Biol. 105:1987;1163-1173.
6. Edsall J.T., Foster J.F., Scheinberg I.H. Studies on double refraction of flow. III. Human fibrinogen and fraction I of human plasma. Am. J. Chem. Soc. 69:1947;2731-2738.
7. Engvall E., Ruoslahti E. Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int. J. Cancer. 20:1977;1-5.
8. Gahmberg C.G., Hakomori S.I. Altered growth behavior of malignant cells associated with changes in externally labeled glycoprotein and glycolipid. Proc. Natl. Acad. Sci. USA. 70:1973;3329-3333.
9. Ghiso J., Rostagno A., Gardella J.E., Liem L., Gorevic P.D., Frangione B. 109-amino-acid C-terminal fragment of Alzheimer's-disease amyloid precursor protein contains a sequence, -RHDS-, that promotes cell adhesion. Biochem. J. 288:1992;1053-1059.
10. Hayman E.G., Pierschbacher M.D., Ohgren Y., Ruoslahti E. Serum spreading factor (vitronectin) is present at the cell surface and in tissues. Proc. Natl. Acad. Sci. USA. 80:1983;4003-4007.
11. Hood L., Huang H.V., Dreyer W.J. The area-code hypothesis: the immune system provides clues to understanding the genetic and molecular basis of cell recognition during development. J. Supramol. Struct. 7:1977;531-559.
12. Hynes R.O. Alteration of cell-surface proteins by viral transformation and by proteolysis. Proc. Natl. Acad. Sci. USA. 70:1973;3170-3174.
13. Hynes R.O. A reevaluation of integrins as regulators of angiogenesis. Nat. Med. 8:2002;918-921.
14. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell. 110:2002;673-687.
15. Kaprielian Z., Patterson P.H. The molecular basis of retinotectal topography. Bioessays. 16:1994;1-11.
16. Kim S., Bell K., Mousa S.A., Varner J.A. Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin. Am. J. Pathol. 156:2000;1345-1362.
17. Klebe R.J. Isolation of a collagen-dependent cell attachment factor. Nature. 250:1974;248-251.
18. Kleinman H.K., Martin G.R., Fishman P.H. Ganglioside inhibition of fibronectin-mediated cell adhesion to collagen. Proc. Natl. Acad. Sci. USA. 76:1979;3367-3371.
19. Kodandapani R., Veerapandian B., Kunicki T.J., Ely K.R. Crystal structure of the OPG2 Fab. An antireceptor antibody that mimics an RGD cell adhesion site. J. Biol. Chem. 270:1995;2268-2273.
20. Margoliash E., Schenck J.R., Hargie M.P., et al. Characterization of specific cell aggregating materials from sponge cells. Biochem. Biophys. Res. Commun. 20:1965;383-388.
21. Nilsson F., Kosmehl H., Zardi L., Neri D. Targeted delivery of tissue factor to the ED-B domain of fibronectin, a marker of angiogenesis, mediates the infarction of solid tumors in mice. Cancer Res. 61:2001;711-716.
22. Obara M., Kang M.S., Yamada K.M. Site-directed mutagenesis of the cell-binding domain of human fibronectin: separable, synergistic sites mediate adhesive function. Cell. 53:1988;649-657.
23. Pearlstein E. Plasma membrane glycoprotein which mediates adhesion of fibroblasts to collagen. Nature. 262:1976;497-500.
24. Pierschbacher M.D., Hayman E.G., Ruoslahti E. Location of the cell attachment sites in fibronectin using monoclonal antibodies and proteolytic fragments of the molecule. Cell. 26:1981;259-267.
25. Pierschbacher M.D., Ruoslahti E. The cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature. 309:1984;30-33.
26. Pierschbacher M.D., Ruoslahti E. Influence of stereochemistry of the sequence Arg-Gly-Asp-Xxx on binding specificity in cell adhesion. J. Biol. Chem. 262:1987;17294-17298.
27. Pierschbacher M.D., Ruoslahti E., Sundelin J., Lind P., Peterson P.A. The cell attachment domain of fibronectin - determination of the primary structure. J. Biol. Chem. 257:1982;9593-9597.
28. Plow E.F., Pierschbacher M.D., Ruoslahti E., Marguerie G.A., Ginsberg M.H. The effect of Arg-Gly-Asp containing peptides on fibrinogen and von Willebrand factor binding to platelets. Proc. Natl. Acad. Sci. USA. 82:1985;8057-8061.
29. Pytela R., Pierschbacher M.D., Ruoslahti E. Identification and isolation of a 140 kilodalton cell surface glycoprotein with properties of a fibronectin receptor. Cell. 40:1985a;191-198.
30. Pytela R., Pierschbacher M.D., Ruoslahti E. A 125/115 kd cell surface receptor specific for vitronectin interacts with the Arg-Gly-Asp adhesion sequence derived from fibronectin. Proc. Natl. Acad. Sci. USA. 82:1985b;5766-5770.
31. Ruoslahti E. RGD and other recognition sequences for integrins. Annu. Rev. Cell Dev. Biol. 12:1996;697-715.
32. Ruoslahti E. Specialization of tumour vasculature. Nat. Rev. Cancer. 2:2002;83-90.
33. Ruoslahti E., Pierschbacher M.D. New perspectives in cell adhesion: RGD and integrins. Science. 238:1987;491-497.
34. Ruoslahti E., Rajotte D. An address system in the vasculature of normal tissues and tumors. Annu. Rev. Immunol. 18:2000;813-827.
35. Ruoslahti E., Vaheri A. Novel human serum protein from fibroblast plasma membrane. Nature. 248:1974;789-791.
36. Ruoslahti E., Vaheri A., Kuusela P., Linder E. Fibroblast surface antigen: a new serum protein. Biochim. Biophys. Acta. 322:1973;352-358.
37. Sano K., Tanihara H., Heimark R.L., et al. Protocadherins: a large family of cadherin-related molecules in central nervous system. EMBO J. 12:1993;2249-2256.
38. Scarborough R.M., Rose J.W., Hsu M.A., et al. A GPIIb-IIIa-specific integrin antagonist from the venom of Sistrurus m. barbouri. J. Biol. Chem. 266:(15):1991;9359-9362.
39. Suzuki S., Oldberg A., Hayman E.G., Pierschbacher M.D., Ruoslahti E. Complete amino acid sequence of human vitronectin deduced from cDNA. Similarity of cell attachment sites in vitronectin and fibronectin. EMBO J. 4:1985;2519-2524.
40. Wu Q., Maniatis T. A striking organization of a large family of human neural cadherin-like cell adhesion genes. Cell. 97:1999;779-790.
41. Xiong J.P., Stehle T., Zhang R., et al. Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand. Science. 296:2002;151-155.
42. Yamada K.M., Kennedy D.W. Dualistic nature of adhesive protein function: fibronectin and its biologically active peptide fragments can autoinhibit fibronectin function. J. Cell Biol. 99:1984;29-36.
43. Yamada K.M., Weston J.A. Isolation of a major cell surface glycoprotein from fibroblasts. Proc. Natl. Acad. Sci. USA. 71:1974;3492-3496.